Want to join the conversation?
$MNK 3Q15 Q&A: Nachman of Goldman asked on OFIRMEV, are you giving up any economics to back on some of formularies. Mark replied yes, we have given up some economics, but certainly it has been to our advantage typically to do that to preserve some volume. But the equation, obviously has been quite favorable and in favor MNK.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.